fulvestrant has been researched along with osteoprotegerin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunstan, CR; Hofbauer, LC; Khosla, S; Lacey, DL; Riggs, BL; Spelsberg, TC | 1 |
| Blaschke, S; Emons, G; Gründker, C; Hofbauer, LC; Siggelkow, H; Viereck, V | 1 |
| Colin, C; De Wilde, A; Lieberherr, M; Pointillart, A | 1 |
| Chaumaz, G; Cournot, G; Lieberherr, M; Pointillart, A; Rassi, CM | 1 |
| Fukuyama, T; Hashiramoto, A; Kitagawa, A; Kurosaka, M; Mitani, M; Miura, Y; Saura, R; Shiozawa, S; Yoshiya, S | 1 |
| Emons, G; Friess, SC; Frosch, KH; Gründker, C; Hofbauer, LC; Nisslein, T; Raddatz, D; Schoppet, M; Viereck, V | 1 |
| Härkönen, PL; Hentunen, TA; Michael, H; Väänänen, HK | 1 |
| Chen, WF; Wong, MS | 1 |
| Härkönen, PL; Hentunen, TA; Kangas, L; Michael, H; Väänänen, HK | 1 |
| Chen, WF; Lai, WP; Leung, PC; Mok, SK; Wang, XL; Wong, MS; Yao, XS | 1 |
| Li, XP; Liao, EY; Luo, XH; Wang, M; Wang, QP; Xie, H; Yang, L | 1 |
| Chow, HK; Lai, WP; Leung, PC; Mok, SK; Pang, WY; Wang, XL; Wong, KC; Wong, MS; Yao, XS | 1 |
| Manokawinchoke, J; Osathanon, T; Pavasant, P; Ritprajak, P | 1 |
| Li, L; Li, LZ; Li, ZY; Sun, J; Sun, WJ; Wang, C; Wang, Y; Yu, LR; Zhang, YL; Zhao, Y | 1 |
14 other study(ies) available for fulvestrant and osteoprotegerin
| Article | Year |
|---|---|
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells.
Topics: Cells, Cultured; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Fulvestrant; Gene Expression; Glycoproteins; Humans; Osteoblasts; Osteoprotegerin; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; RNA, Messenger; Time Factors | 1999 |
Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts.
Topics: Adult; Dexamethasone; Drug Interactions; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Genistein; Glycoproteins; Growth Inhibitors; Humans; Male; Osteoblasts; Osteoprotegerin; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Receptors, Tumor Necrosis Factor; RNA, Messenger | 2002 |
A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets.
Topics: Alkaline Phosphatase; Animals; Blotting, Western; Bone and Bones; Calcium; Carrier Proteins; Cell Division; Cells, Cultured; Core Binding Factor Alpha 1 Subunit; Cyclic AMP; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Non-Steroidal; Female; Fulvestrant; Glycoproteins; Isoflavones; Membrane Glycoproteins; Neoplasm Proteins; Osteoblasts; Osteocalcin; Osteoprotegerin; Procollagen; Progesterone; RANK Ligand; Receptors, Calcitriol; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Receptors, Tumor Necrosis Factor; Swine; Time Factors; Transcription Factors | 2004 |
Modulation of osteoclastogenesis in porcine bone marrow cultures by quercetin and rutin.
Topics: Animals; Antioxidants; Apoptosis; Bone Marrow Cells; Cell Count; Cells, Cultured; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Glycoproteins; Mesenchymal Stem Cells; Osteoclasts; Osteoprotegerin; Quercetin; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Rutin; Swine | 2005 |
Estrogen specifically stimulates expression and production of osteoprotegerin from rheumatoid synovial fibroblasts.
Topics: Arthritis, Rheumatoid; Carrier Proteins; Cells, Cultured; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrogens; Fibroblasts; Fulvestrant; Glycoproteins; Humans; Membrane Glycoproteins; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; RNA, Messenger; Synovial Membrane; Tamoxifen; Up-Regulation | 2005 |
Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
Topics: 2-Propanol; Adult; Alkaline Phosphatase; Carrier Proteins; Cell Differentiation; Cells, Cultured; Cimicifuga; Dexamethasone; Dose-Response Relationship, Drug; Enzyme Activation; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Gene Expression; Glycoproteins; Humans; Male; Membrane Glycoproteins; Menopause; Osteoblasts; Osteocalcin; Osteoporosis, Postmenopausal; Osteoprotegerin; Plant Extracts; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Progesterone; Receptors, Tumor Necrosis Factor; RNA, Messenger | 2005 |
Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Topics: Acid Phosphatase; Adult; Androgen Antagonists; Animals; Bone Resorption; Carrier Proteins; Cattle; Cell Differentiation; Cell Line, Tumor; Coculture Techniques; Dexamethasone; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Flutamide; Fulvestrant; Glycoproteins; Humans; Isoenzymes; Lipopolysaccharide Receptors; Macrophage Colony-Stimulating Factor; Male; Membrane Glycoproteins; Monocytes; Osteoclasts; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Tartrate-Resistant Acid Phosphatase; Testosterone; Tumor Necrosis Factor-alpha | 2005 |
Genistein modulates the effects of parathyroid hormone in human osteoblastic SaOS-2 cells.
Topics: Alkaline Phosphatase; Carrier Proteins; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Estradiol; Estrogen Antagonists; Fulvestrant; Gene Expression; Genistein; Glycoproteins; Humans; Immunoblotting; Membrane Glycoproteins; Osteoblasts; Osteoprotegerin; Parathyroid Hormone; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stimulation, Chemical | 2006 |
Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.
Topics: Animals; Apoptosis; Bone Resorption; Cattle; Cell Differentiation; Cell Line, Tumor; Cells, Cultured; Coculture Techniques; Dexamethasone; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Fulvestrant; Humans; Lipopolysaccharide Receptors; Macrophage Colony-Stimulating Factor; Monocytes; Osteoclasts; Osteoprotegerin; Raloxifene Hydrochloride; RANK Ligand; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors; Tumor Necrosis Factor-alpha | 2007 |
Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells.
Topics: Alkaline Phosphatase; Animals; Bone Density; Bone Density Conservation Agents; Cell Line; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Femur; Flavonoids; Fulvestrant; Gene Expression Regulation; Mice; Mice, Inbred C57BL; Osteoblasts; Osteoporosis; Osteoprotegerin; Ovariectomy; Phosphorylation; RANK Ligand; Rats; RNA, Messenger; Tibia; Time Factors; Tomography, X-Ray Computed; Transfection | 2010 |
Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand.
Topics: Adiponectin; Anisomycin; Coculture Techniques; Enzyme Activation; Estradiol; Female; Fulvestrant; Gene Expression Regulation; Humans; Leukocytes, Mononuclear; Lipopolysaccharide Receptors; MAP Kinase Signaling System; Osteoblasts; Osteogenesis; Osteoprotegerin; p38 Mitogen-Activated Protein Kinases; RANK Ligand; Receptors, Estrogen; RNA, Messenger; Time Factors | 2012 |
Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone.
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Estradiol; Female; Femur; Flavanones; Flavonoids; Fulvestrant; Lumbar Vertebrae; Mice; Mice, Inbred C57BL; Osteoblasts; Osteoclasts; Osteoporosis; Osteoprotegerin; Ovariectomy; Phytoestrogens; Phytotherapy; Plant Extracts; Polypodiaceae; Rats; RNA, Messenger; Tibia | 2013 |
Estradiol induces osteoprotegerin expression by human dental pulp cells.
Topics: Blotting, Western; Cell Survival; Cells, Cultured; Dental Pulp; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Estradiol; Fulvestrant; Humans; Immunohistochemistry; MAP Kinase Signaling System; Osteoprotegerin; Phosphorylation; RANK Ligand; Receptors, Estrogen; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction | 2016 |
Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells.
Topics: Cell Line; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Fulvestrant; Humans; Interleukin-6; Isoflavones; Nuclear Receptor Coactivator 1; Osteoblasts; Osteoprotegerin; Raloxifene Hydrochloride; RANK Ligand; RNA, Small Interfering | 2016 |